Year: 2020
Type: article
Abstract: The ATP binding cassette subfamily B member 4 (ABCB4) gene on chromosome 7 encodes the ABCB4 protein (alias multidrug resistance protein 3 [MDR3]), a P-glycoprotein in the canalicular membrane of the hepatocytes that acts as a translocator of phospholipids into bile. Several variants in ABCB4 have been shown to cause ABCB4 deficiency, accounting for a disease spectrum ranging from progressive familial cholestasis type 3 to less severe conditions like low phospholipid-associated cholelithiasis, intrahepatic cholestasis of pregnancy or drug-induced liver injury. Furthermore, whole genome sequencing has shown that ABCB4 variants are associated with an increased incidence of gallstone disease, gallbladder and bile duct carcinoma, liver cirrhosis or elevated liver function tests. Diagnosis of ABCB4 deficiency-related diseases is based on clinical presentation, serum biomarkers, imaging techniques, liver histology and genetic testing. Nevertheless, the clinical presentation can vary widely and clear genotype-phenotype correlations are currently lacking. Ursodeoxycholic acid is the most commonly used medical treatment, but its efficacy has yet to be proven in large controlled clinical studies. Future pharmacological options may include stimulation/restoration of residual function by chaperones (e.g. 4-phenyl butyric acid, curcumin) or induction of ABCB4 transcription by FXR (farnesoid X receptor) agonists or PPARα (peroxisome proliferator-activated receptor-α)-ligands/fibrates. Orthotopic liver transplantation remains the last and often only therapeutic option in cirrhotic patients with end-stage liver disease or patients with intractable pruritus.
Source: Journal of Hepatology
Institution: Medical University of Vienna
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Keywords: ABCB4, MDR3, progressive familial intrahepatic cholestasis type 3, gallstones, intrahepatic cholestasis of pregnancy, drug-induced liver injury, cholestatic liver disease, genotype-phenotype correlation, ursodeoxycholic acid, 4-phenylbutyric acid, curcumin, farnesoid X receptor agonist, PPARα agonist, orthotopic liver transplantation, pruritus
Open Access status: hybrid
Estimated APC paid: $3,000
Funder: Austrian Science Fund
OpenAlex ID: W3021883529
